Executive Officer Compensation Schedule as of January 1, 2020
Contract Categories:
Human Resources
›
Compensation Agreements
Summary
This document lists the annual base salaries for the company's executive officers as of January 1, 2020. It names each executive, their title, and their respective salary. It also notes a recent change in the Chief Financial Officer position, with Scott E. Lamb retiring and Brian M. Bonnell being promoted to the role. The document serves as a record of executive compensation and recent leadership transitions.
EX-10.5 2 exhibit105executiveofficer.htm EX-10.5 Document
Exhibit 10.5
Executive Officer Compensation
The annual base salaries for our executive officers as of January 1, 2020 are as follows:
Name | Title | ||||||||||||||||
Vivek Jain | Chairman of the Board and Chief Executive Officer | $ | 650,000 | ||||||||||||||
Christian Voigtlander | Chief Operating Officer | $ | 420,000 | ||||||||||||||
Brian M. Bonnell | Chief Financial Officer and Treasurer | $ | 395,000 | ||||||||||||||
Scott E. Lamb* | Former Chief Financial Officer and Treasurer | $ | 395,150 | ||||||||||||||
Daniel Woolson | Corporate Vice President, General Manager - Infusion Systems | $ | 300,000 | ||||||||||||||
Virginia Sanzone | Corporate Vice President, General Counsel | $ | 300,000 |
____________________
* Scott E. Lamb, our former Chief Financial Officer and Treasurer, retired from that role effective March 3, 2020 , and continued to serve as an advisor to the Company for a transition period ending on April 3, 2020. Effective March 3, 2020, Mr. Bonnell was promoted to Chief Financial Officer and Treasurer from his former position of Corporate Vice President, Finance.